POLE and neoplasm: Based the relevance of each piece of evidence, we adapted the ACMG/AMP variant classification guidelines to the particular conditions of POLE and POLD1 ED variants and to the relevance of the functional information gathered, i.e., tumor mutational signatures, yeast repair assay results, and alteration of the DNA binding pocket (Table S3).